Navigation Links
Aegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer
Date:1/8/2009

MONTREAL, Jan. 8 /PRNewswire/ - Aegera Therapeutics Inc. announced today the dosing of the first patient in a randomized Phase 2 study of AEG35156, their targeted antisense therapeutic in mid-stage development for multiple oncology indications.

The study, entitled "A Phase 2, Multicenter, Open-Label, Randomized Study of the X-Linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 Given In Combination With Carboplatin/Paclitaxel or the Combination of Carboplatin/Paclitaxel Alone In Patients With Advanced Non Small Cell Lung Cancer" is being conducted in the United States in collaboration with U.S. Oncology and additional sites will be opened in Canada. The Principal Investigator of this study is Dr. Robert M. Jotte, of the Rocky Mountain Cancer Center in Denver, Colorado.

The primary objective of this study is to compare the efficacy of the standard of care for this patient population to the standard of care in combination with AEG35156. Recruitment for this trial is expected to be completed prior to the end of 2009.

"Preliminary evidence of activity was observed in the Phase 1 portion of this study and encouraged us to amend the clinical protocol to provide for a control arm for the Phase 2 portion of the study" stated Dr. Jacques Jolivet, Senior Vice-President of Clinical Development of Aegera.

"Our clinical program around AEG35156 continues to accelerate and expand as we seek to move this therapeutic forward to more advanced stages of clinical development," added Aegera's President and Chief Executive Officer, Dr. Michael J. Berendt. "The initiation of this randomized Phase 2 study in lung cancer follows very shortly after our publication of positive clinical data from our Phase 1/2 study in AML at the recent ASH conference in San Francisco and represents the first of multiple new clinical trials for this innovative therapy that we hope to announce over the course of 2009."

About AEG35156

Ca
'/>"/>

SOURCE AEGERA THERAPEUTICS INC.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Aegera Therapeutics phase 1/2 clinical trial results selected for oral presentation at 2008 ASH Annual Meeting
2. Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment
3. Aegera Therapeutics welcomes two experienced executives to its board of directors
4. Aegera initiates Phase 1 clinical trial of AEG33773 - A small molecule in development for diabetic neuropathic pain
5. Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs
6. Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors
7. Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market
8. Horizon Therapeutics Announces Senior Management Appointments
9. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco
10. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
11. Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Though health care jobs continued to be ... of Labor Statistics -- the increase was far below the ... health care jobs were added in home health care and ... 6,000 jobs. Overall, the U.S. unemployment rate stayed flat at ... reported that a total of just over 36,000 job cuts ...
(Date:6/18/2013)... June 18, 2013 PathoGenetix, ... system for rapid bacterial strain typing, announced today ... the company as Vice President of Engineering. Dr. ... the company’s RESOLUTION™ Microbial Genotyping System . ... benchtop instrument, pathogen-specific assay kits, database and software, ...
(Date:6/18/2013)... On June 11, 2013 the Centers for Medicare ... memorandum concluding that FDG Position Emission Tomography (PET) is ... strategy, and the agency ended the requirement for ... was developed jointly by the ACR and WMIS as ... Evidence Development (CED) program to determine if FDG-PET scans ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 NASA ... in March that helps better monitor potentially harmful chemicals ... microAnalyzer V2.0, which was developed by Draper Laboratory ... Station. , Astronauts breathe air that is processed and ... harmful compounds in the air, even in trace amounts, ...
Breaking Biology Technology:MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 2WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 3New Monitoring System Will Better Protect NASA Astronauts on ISS 2
... to be encouraged by the numerous positive signs that biotech ... a few: , ,& bull; The coming of the Olympics ... The continued acquisition of Midwest biotech companies by Big ... Midwest products and technology, the flip side of this is ...
... Madison, Wis. - Two University of Wisconsin-Madison faculty ... and public policy to train students how to apply ... about the neurobiology of violence and aggression," says Clark ... one of two co-organizers of the new program. "Or ...
... and agricultural equipment manufacturer Gehl Co. has developed ... control boom functions using a compact, wireless remote control pendant ... platform. The hand-held pendant can be used to raise, lower, ... engine. , ,"Our goal was to add a new ...
Cached Biology Technology:Midwest biotech on a roll 2Midwest biotech on a roll 3Midwest biotech on a roll 4UW offers new program in neuroscience and public policy 2
(Date:6/17/2013)... A Kansas State University research associate has received a ... ways to prevent the spread of malaria. , Bart ... Institutes of Health,s National Research Service Award Individual Postdoctoral ... the seventh Kansas State University researcher to receive the ... currently hold such an award. , Bryant, a university ...
(Date:6/17/2013)... of mining shale gas, is widespread across Pennsylvania, covering ... research in the Annals of the New York ... biodiversity including pollution from toxic chemicals, the building of ... "Shale gas has engendered a great deal of controversy, ... effects on biological diversity and resources have scarcely been ...
(Date:6/16/2013)... group together and move around the body called ,chase ... by scientists at UCL. , Published in Nature ... that occurs when cancer cells interact with healthy cells in ... that cancer cells recruit healthy cells and use them to ... how it could be controlled to design new therapies against ...
Breaking Biology News(10 mins):NIH fellowship helps researcher fight malaria, understand mosquito immunity 2'Chase and run' cell movement mechanism explains process of metastasis 2
... arsenal against cancer: Nanoparticles that identify, target and kill ... Led by Carl Batt, the Liberty Hyde Bailey Professor ... something like a dumbbell made of gold sandwiched ... antibodies, which target a molecule found only in colorectal ...
... existence of God and the nature of religion, two ... rooted in evolutionary biology with a focus on brain ... Lionel Tiger and pioneering neuroscientist Michael McGuire elucidate perennial ... it arise? What is its source? And why does ...
... for the most common cancers could soon come from cutting-edge ... the ESMO Conference on Sarcoma and GIST, to be held ... and some of the world,s leading experts will discuss exciting ... muscle, blood vessels, deep skin tissues, nerves and the tissues ...
Cached Biology News:Like little golden assassins, 'smart' nanoparticles identify, target and kill cancer cells 2Which came first: Religion or the brain? 2Spotlight on rare tumors in hunt for new cancer treatments 2
... Captivate magnetic separator for six ... in conjunction with the Captivate ... or other magnetic particles and ... microcentrifuge tubes. Cell Biology Cell ...
Because it is manufactured at our ISO 9001–certified facilities in Eugene, Oregon, we can guarantee that FluoroPure Grade DAPI is greater than or equal to 98% pure by HPLC....
Edited by D. Patel (1994) Comprehensive data on gel electrophoresis of proteins, nucleic acids, nucleoproteins and carbohydrates....
...
Biology Products: